Literature DB >> 11679433

Plasma free Fatty Acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes.

M Mensink1, E E Blaak, M A van Baak, A J Wagenmakers, W H Saris.   

Abstract

The objective of this study was to investigate to what extent disturbances in fatty acid metabolism found in type 2 diabetes are already present in subjects at high risk for developing diabetes (i.e., impaired glucose tolerance [IGT]). Components of fatty acid metabolism were measured in male subjects with IGT during postabsorptive conditions and during 60 min of exercise (50% VO(2max)) with the use of the stable isotope tracer [U-(13)C]palmitate in combination with indirect calorimetry, and those values were compared with previously published findings in male type 2 diabetic and male obese subjects. No differences were found between groups in energy expenditure and in total fat and carbohydrate oxidation. Rate of appearance and rate of disappearance of plasma free fatty acid (FFA) were lower in subjects with IGT and type 2 diabetes compared with obese subjects (P < 0.05). Plasma FFA oxidation was lower in subjects with IGT and type 2 diabetes compared with obese subjects at rest and tended to be lower during exercise (rest: 3.7 +/- 0.3, 4.4 +/- 0.6, and 6.9 +/- 1.0 micromol. kg fat-free mass [FFM](-1). min(-1), P < 0.01; exercise: 15.0 +/- 1.7, 14.1 +/- 1.9, and 19.6 +/- 1.5 micromol. kg FFM(-1). min(-1) for IGT, type 2 diabetic, and obese subjects, respectively, P = 0.07). Triglyceride-derived fatty acid oxidation, however, was elevated in subjects with IGT and type 2 diabetes during exercise (3.6 +/- 1.4, 1.4 +/- 1.4, and -4.0 +/- 2.0 micromol. kg FFM(-1). min(-1) for IGT, type 2 diabetic, and obese subjects, respectively; P < 0.05). These data demonstrate that male subjects with a prediabetic condition (IGT) have the same defects in fatty acid utilization as subjects with type 2 diabetes, suggesting that these disturbances may play an important role in the progression from IGT to type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11679433     DOI: 10.2337/diabetes.50.11.2548

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  33 in total

1.  Skeletal muscle interstitial fluid metabolomics at rest and associated with an exercise bout: application in rats and humans.

Authors:  Jie Zhang; Sudeepa Bhattacharyya; Robert C Hickner; Alan R Light; Christopher J Lambert; Bruce K Gale; Oliver Fiehn; Sean H Adams
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-11-06       Impact factor: 4.310

2.  The role of fatty acid unsaturation in minimizing biophysical changes on the structure and local effects of bilayer membranes.

Authors:  Sukit Leekumjorn; Hyun Ju Cho; Yifei Wu; Neil T Wright; Amadeu K Sum; Christina Chan
Journal:  Biochim Biophys Acta       Date:  2009-04-14

Review 3.  Skeletal muscle insulin resistance: roles of fatty acid metabolism and exercise.

Authors:  Lorraine P Turcotte; Jonathan S Fisher
Journal:  Phys Ther       Date:  2008-09-18

4.  Acylcarnitines as markers of exercise-associated fuel partitioning, xenometabolism, and potential signals to muscle afferent neurons.

Authors:  Jie Zhang; Alan R Light; Charles L Hoppel; Caitlin Campbell; Carol J Chandler; Dustin J Burnett; Elaine C Souza; Gretchen A Casazza; Ronald W Hughen; Nancy L Keim; John W Newman; Gary R Hunter; Jose R Fernandez; W Timothy Garvey; Mary-Ellen Harper; Oliver Fiehn; Sean H Adams
Journal:  Exp Physiol       Date:  2016-12-12       Impact factor: 2.969

5.  Reduced whole-body lipid oxidation is associated with insulin resistance, but not with intramyocellular lipid content in offspring of type 2 diabetic patients.

Authors:  G Lattuada; F Costantino; A Caumo; P Scifo; F Ragogna; F De Cobelli; A Del Maschio; L Luzi; G Perseghin
Journal:  Diabetologia       Date:  2005-03-10       Impact factor: 10.122

6.  Palmitoyl-carnitine production by blood cells associates with the concentration of circulating acyl-carnitines in healthy overweight women.

Authors:  Maria Chondronikola; Rabia Asghar; Xiaojun Zhang; Edgar L Dillon; William J Durham; Zhanpin Wu; Craig Porter; Maria Camacho-Hughes; Yingxin Zhao; Allan R Brasier; Elena Volpi; Melinda Sheffield-Moore; Nicola Abate; Labros Sidossis; Demidmaa Tuvdendorj
Journal:  Clin Nutr       Date:  2016-09-06       Impact factor: 7.324

7.  Increased postprandial nonesterified fatty acid appearance and oxidation in type 2 diabetes is not fully established in offspring of diabetic subjects.

Authors:  François Normand-Lauzière; Frédérique Frisch; Sébastien M Labbé; Patrick Bherer; René Gagnon; Stephen C Cunnane; André C Carpentier
Journal:  PLoS One       Date:  2010-06-04       Impact factor: 3.240

8.  Inhibition of Lipolysis Ameliorates Diabetic Phenotype in a Mouse Model of Obstructive Sleep Apnea.

Authors:  Martin Weiszenstein; Larissa A Shimoda; Michal Koc; Ondrej Seda; Jan Polak
Journal:  Am J Respir Cell Mol Biol       Date:  2016-08       Impact factor: 6.914

9.  Reduced tricarboxylic acid cycle flux in type 2 diabetes mellitus?

Authors:  P Schrauwen; M K C Hesselink
Journal:  Diabetologia       Date:  2008-06-28       Impact factor: 10.122

10.  Lifestyle changes and lipid metabolism gene expression and protein content in skeletal muscle of subjects with impaired glucose tolerance.

Authors:  M Mensink; E E Blaak; H Vidal; T W A De Bruin; J F C Glatz; W H M Saris
Journal:  Diabetologia       Date:  2003-07-11       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.